Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06184867 · ClinicalTrials.gov registry record · NA
Choices About Genetic Testing And Learning Your Risk With Smart Technology
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT06184867 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 50 participants.
The verdict
NCT06184867, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study seeks to enhance genetic education and increase the uptake of genetic testing for hereditary cancer risk among cancer survivors. The study will focus on the feasibility and acceptability of a digital intervention designed to improve cancer genomic care. The study objectives are to: 1. Finalize the development and optimize the usability of the CATALYST digital intervention (also known as the relational assistant \[RA\]). 2. Evaluate the feasibility and acceptability of a streamlined cancer genomic care delivery model for cancer survivors. Participants will be randomized to one of two study arms: the RA intervention arm or the enhanced usual care (EUC) arm. 3. Assess the uptake of genetic counseling (GC) and genetic testing (GT) and conduct a process evaluation to identify barriers and facilitators to GC, GT, and engagement with the CATALYST intervention and the RA.
Interventions
- BEHAVIORAL Enhanced Usual Care (EUC)
- BEHAVIORAL Relational Agent (RA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-09-26 |
| Est. Completion | 2025-06-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06184867
The ClinicalTrials.gov registry entry for NCT06184867 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enhanced Usual Care (EUC) is the first listed.
NCT06184867 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06184867 about?
NCT06184867 is a clinical study titled "Choices About Genetic Testing And Learning Your Risk With Smart Technology". This study seeks to enhance genetic education and increase the uptake of genetic testing for hereditary cancer risk among cancer survivors. The study will focus on the feasibility and acceptability of a digital intervention designed to improve cancer genomic care. The study objectives are to: 1. F...
What is the current status of trial NCT06184867?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2023-09-26. Estimated completion is 2025-06-26.
What interventions are being tested in trial NCT06184867?
The interventions under investigation include: Enhanced Usual Care (EUC) (BEHAVIORAL), Relational Agent (RA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06184867?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.